logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shiyuan Zhang

peric hydrogen technologies co., ltd.
H指数:4
被引数:110

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dual transfusion independence and spleen volume reduction are associated with overall survival in patients with myelofibrosis treated with momelotinib: post hoc analyses of SIMPLIFY-1 and MOMENTUM

双输血独立性及脾脏体积缩小与接受莫美洛替尼治疗的骨髓纤维化患者总生存期相关：SIMPLIFY-1和MOMENTUM试验的事后分析

Annals of Hematology
IF2.4
2026-10-080
OAAI
Francesca Palandri; Nicolaas P. M. Schaap; Jérôme Rey; Nikolas von Bubnoff; Andreas Reiter; Juan Carlos Hernández-Boluda; Timothy Devos; Bethan Psaila; Donal P. McLornan; Catherine Ellis; Shiyuan Zhang; Sunkyung Kim; Stephen T. Oh
Spleen volume reduction and transfusion independence with momelotinib vs ruxolitinib and associated overall survival with momelotinib in JAK inhibitor–naive patients with myelofibrosis and anemia: subgroup analyses of SIMPLIFY-1

脾脏体积缩小和输血独立性：比较momelotinib与ruxolitinib，以及momelotinib相关的总生存期，在JAK抑制剂初治伴有贫血的骨髓纤维化患者中的亚组分析：SIMPLIFY-1研究。

Clinical Lymphoma Myeloma and Leukemia
IF2.7
2026-05-010
OAAI
Francesca Palandri; Nicolaas P.M. Schaap; Jerome Rey; Nikolas von Bubnoff; Andreas Reiter; Juan Carlos Hernandez-Boluda; Timothy Devos; Lars Nilsson; Bethan Psaila; Donal P. McLornan; Bryan Strouse; Shiyuan Zhang; Bharat Patel; Jessica Lim; Dwaipayan Patnaik; Stephen T. Oh
Association Between Transfusion Status, Hemoglobin Levels, and Patient-Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis

输血状态、血红蛋白水平与骨髓纤维化患者报告结局的相关性：一项事后临床 trial 分析

Cancer Medicine
IF3.1
2026-04-100
OAAI
Ruben Mesa; Jeanne M. Palmer; Francesca Palandri; Lucia Masarova; Claire N. Harrison; Flora Mazerolle; Manal M'hari; Tom Liu; Shiyuan Zhang; Anna Cardellino; Zhaohui Wang; Catherine E. Ellis; Dwaipayan Patnaik; Antoine Regnault; Thomas W. LeBlanc
Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison

与最佳可用疗法相比，在既往接受过鲁索利替尼治疗的患者中，使用莫美洛替尼的总体生存率：一项匹配调整的间接比较

Annals of Hematology
IF2.4
2026-02-210
OAAI
Francesca Palandri; Venediktos Kapetanakis; Balázs Dobi; Massimo Breccia; Giuseppe A. Palumbo; Elisabetta Abruzzese; Massimiliano Bonifacio; Mario Tiribelli; Elena Maria Elli; Erika Morsia; Filippo Branzanti; Catherine E. Ellis; Nicholas Ballew; Tom Liu; Kelesitse Phiri; Fulya Sen Nikitas; Shiyuan Zhang; Dwaipayan Patnaik
Unlocking Li-Ions from “Cages” and “Shackles” in PVDF-HFP Solid-State Electrolyte through Synergistic Pinning Effect and Competitive Coordination

通过协同锚定效应和竞争性配位作用，从PVDF-HFP固态电解质的“笼子”和“镣铐”中释放Li⁺离子

Advanced Functional Materials
IF19
2025-11-280
PRE
Shiyuan Zhang; Ying Liu; Hong Teng; Aotian Zhang; Tianzong Ma; Zhentong Kong; Nan Zhang; Shuling Qin; Huiyan Wang; Haoyuan Zhu; Ruonan Jing; Chungang Wang; Haiming Xie; Liqun Sun
Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study

描述哮喘患者中度急性加重负担的Extended Salford Lung Study（Ext-SLS）扩展萨尔福德肺脏研究：一项回顾性队列研究

RESPIRATORY RESEARCH
IF5
2025-03-290
OA
Goodall, Emma; Rothnie, Kieran J.; Numbere, Beade; Zhang, Shiyuan; Compton, Chris; Wood, Robert; Tritton, Theo; Wild, Rosie; Small, Mark; Vestbo, Jorgen; Woodcock, Ashley
Overall Survival with Momelotinib Vs Best Available Therapy in Patients with Ruxolitinib-Experienced Myelofibrosis: A Matching-Adjusted Indirect Comparison

与最佳可用疗法相比，momelotinib在既往接受过ruxolitinib治疗的患者中的总体生存率：一项匹配调整间接比较研究

BLOOD
IF23.1
2024-11-051
PRE
Palandri, Francesca; Kapetanakis, Venediktos; Dobi, Balazs; Branzanti, Filippo; Ellis, Catherine; Ballew, Nick; Liu, Tom; Phiri, Kelesitse; Sen Nikitas, Fulya; Biasi, Melania; Zhang, Shiyuan; Patnaik, Dwaipayan

研究方向

暂未获取到该数据
K
Kieran Rothnie
H 指数:19论文数:169被引数:1,726
F
Francesca Palandri
H 指数:50论文数:536被引数:9,445
谢海明 封面图
谢海明
H 指数:51论文数:248被引数:8,957
N
Nan Zhang
H 指数:11论文数:33被引数:313
L
Liqun Sun
H 指数:37论文数:109被引数:5,243
T
Takeo Ishii
H 指数:29论文数:189被引数:2,491
D
David Slade
H 指数:10论文数:80被引数:252
C
Claire Trennery
H 指数:6论文数:29被引数:190
D
Dwaipayan Patnaik
H 指数:2论文数:34被引数:13
J
Joshua Harvey
H 指数:10论文数:65被引数:552